Guggenheim Capital LLC Prothena Corp Public LTD CO Transaction History

Guggenheim Capital LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$19.54 - $26.15 $22,510 - $30,124	-1,152 Reduced 2.59%	43,248 $892,000
Q1 2024 May 14, 2024	BUY	$24.75 - $40.66 $518,240 - $851,379	20,939 Added 89.25%	44,400 $1.1 Million
Q4 2023 Feb 14, 2024	BUY	$32.31 - $52.32 $262,292 - $424,733	8,118 Added 52.91%	23,461 $852,000
Q3 2023 Nov 14, 2023	BUY	$47.3 - $70.6 $7,709 - $11,507	163 Added 1.07%	15,343 $740,000
Q2 2023 Aug 11, 2023	SELL	$48.26 - $78.59 $106,654 - $173,683	-2,210 Reduced 12.71%	15,180 $1.04 Million
Q1 2023 May 10, 2023	BUY	$46.97 - $58.27 $816,808 - $1.01 Million	17,390 New	17,390 $842,000
Q3 2022 Nov 14, 2022	SELL	$25.16 - $60.63 $10,592 - $25,525	-421 Reduced 0.55%	75,795 $4.6 Million
Q2 2022 Aug 15, 2022	BUY	$22.73 - $39.98 $1.73 Million - $3.05 Million	76,216 New	76,216 $2.07 Million
Q2 2018 Aug 14, 2018	SELL	$10.99 - $44.21 $1.08 Million - $4.35 Million	-98,323 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$27.95 - $45.04 $568,475 - $916,068	20,339 Added 26.08%	98,323 $3.61 Million
Q4 2017 Feb 14, 2018	BUY	$35.44 - $63.76 $217,707 - $391,677	6,143 Added 8.55%	77,984 $2.92 Million
Q3 2017 Nov 14, 2017	BUY	$53.83 - $67.75 $3.87 Million - $4.87 Million	71,841	71,841 $4.65 Million

184

42.7M

162K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $714M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.